At the Heart in Diabetes CME Conference, speakers highlighted four recent reports published in the Journal of the American ...

The drug in question, a selective aldose reductase inhibitor called govorestat, was being evaluated in the phase 2/3 Inspire study of 56 patients with a progressive neuromuscular disease called ...

Aim: To examine the relation between aldose reductase (AR) and the development and progression of diabetic retinopathy by comparing the erythrocyte AR levels with the prevalence of diabetic ...

The network for cardiac fuel metabolism contains intricate sets of interacting pathways that result in both ATP-producing and non–ATP-producing end points for each class of energy substrates. The most ...

Studies in the Diabetes Research Program include advanced glycation end products, aldose reductase, and the effect of diabetes on white blood cell function. During the past five years, the division ...

Get article recommendations from ACS based on references in your Mendeley library. Pair your accounts.

This study presents compelling evidence that the denitrosylase SCoR2 regulates cardioprotective metabolic reprogramming in the heart following ischemia/reperfusion injury. The findings are supported ...

Article subjects are automatically applied from the ACS Subject Taxonomy and describe the scientific concepts and themes of the article. In this review, we discuss both historical and recent advances ...